BMO Capital Markets Initiates Coverage on Phreesia (NYSE:PHR)

Equities research analysts at BMO Capital Markets began coverage on shares of Phreesia (NYSE:PHR) in a report released on Thursday, Marketbeat.com reports. The firm set an “outperform” rating and a $32.00 price target on the stock. BMO Capital Markets’ price objective points to a potential upside of 46.97% from the company’s previous close.

Several other equities analysts also recently weighed in on PHR. Citigroup reiterated an “outperform” rating on shares of Phreesia in a research report on Monday, September 8th. KeyCorp decreased their target price on shares of Phreesia from $35.00 to $32.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. Mizuho began coverage on shares of Phreesia in a report on Wednesday, August 27th. They issued an “outperform” rating and a $36.00 target price for the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Phreesia in a research note on Friday, October 31st. Finally, Stephens reissued an “overweight” rating and set a $32.00 price objective on shares of Phreesia in a research note on Wednesday, September 3rd. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Phreesia presently has a consensus rating of “Moderate Buy” and an average target price of $33.71.

Phreesia Stock Performance

Shares of PHR opened at $21.77 on Thursday. The company’s 50 day simple moving average is $23.36 and its 200-day simple moving average is $25.82. The company has a current ratio of 2.12, a quick ratio of 2.12 and a debt-to-equity ratio of 0.02. The firm has a market cap of $1.30 billion, a PE ratio of -51.84 and a beta of 0.74. Phreesia has a 12-month low of $17.07 and a 12-month high of $32.76.

Phreesia (NYSE:PHR) last released its earnings results on Thursday, September 4th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.08. The company had revenue of $117.26 million for the quarter, compared to analysts’ expectations of $116.39 million. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.The firm’s quarterly revenue was up 14.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.03) EPS. Phreesia has set its FY 2026 guidance at EPS. As a group, equities analysts predict that Phreesia will post -1.1 EPS for the current year.

Insider Transactions at Phreesia

In other Phreesia news, insider Evan Roberts sold 45,147 shares of the business’s stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $32.02, for a total value of $1,445,606.94. Following the sale, the insider owned 727,768 shares of the company’s stock, valued at $23,303,131.36. The trade was a 5.84% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Balaji Gandhi sold 4,183 shares of the company’s stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total transaction of $97,380.24. Following the completion of the sale, the chief financial officer directly owned 99,125 shares in the company, valued at approximately $2,307,630. The trade was a 4.05% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 92,244 shares of company stock valued at $2,680,720 in the last ninety days. 5.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Phreesia

A number of large investors have recently bought and sold shares of PHR. Vanguard Group Inc. increased its holdings in Phreesia by 8.3% in the third quarter. Vanguard Group Inc. now owns 5,704,786 shares of the company’s stock valued at $134,177,000 after purchasing an additional 437,462 shares during the last quarter. Greenhouse Funds LLLP grew its position in shares of Phreesia by 16.8% during the 3rd quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock worth $91,317,000 after buying an additional 557,265 shares during the period. Champlain Investment Partners LLC increased its stake in shares of Phreesia by 20.0% in the 1st quarter. Champlain Investment Partners LLC now owns 2,946,489 shares of the company’s stock valued at $75,312,000 after acquiring an additional 490,340 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Phreesia by 108.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,644,988 shares of the company’s stock valued at $67,606,000 after acquiring an additional 1,377,904 shares during the last quarter. Finally, Franklin Resources Inc. raised its position in shares of Phreesia by 1.9% in the 3rd quarter. Franklin Resources Inc. now owns 1,553,192 shares of the company’s stock valued at $36,531,000 after acquiring an additional 28,941 shares during the period. 92.10% of the stock is currently owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.